"Sample Size" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of units (persons, animals, patients, specified circumstances, etc.) in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. (From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p95)
| Descriptor ID |
D018401
|
| MeSH Number(s) |
E05.318.780.762 E05.581.500.902 N05.715.360.780.692 N06.850.520.445.762
|
| Concept/Terms |
Sample Size- Sample Size
- Sample Sizes
- Size, Sample
- Sizes, Sample
|
Below are MeSH descriptors whose meaning is more general than "Sample Size".
Below are MeSH descriptors whose meaning is more specific than "Sample Size".
This graph shows the total number of publications written about "Sample Size" by people in this website by year, and whether "Sample Size" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 3 | 4 |
| 2007 | 0 | 3 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 6 | 6 |
| 2013 | 1 | 2 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 3 | 4 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 2 | 3 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sample Size" by people in Profiles.
-
The Importance of Statistical Significance in Drawing Conclusions in Clinical Research. Spine (Phila Pa 1976). 2022 05 01; 47(9):E432.
-
Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial. Am Heart J. 2021 05; 235:158-162.
-
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan. Biometrics. 2020 06; 76(2):595-598.
-
What does it mean to be a physician? Exploring social imaginaries of first-year medical students. Int J Med Educ. 2020 Mar 27; 11:76-80.
-
Nonradioactive and Radioactive Telomerase Assays for Detecting Diminished Telomerase Activity in Cancer Cells after Treatment with Retinoid. Methods Mol Biol. 2019; 2019:257-273.
-
Planning and Conducting the ISCHEMIA Trial. Circulation. 2018 10 02; 138(14):1384-1386.
-
Genome-Wide Mapping of Gene-Phenotype Relationships in Experimentally Evolved Populations. Mol Biol Evol. 2018 08 01; 35(8):2085-2095.
-
Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for a randomized controlled trial. Trials. 2018 Mar 14; 19(1):181.
-
Imbalance control in clinical trial subject randomization-from philosophy to strategy. J Clin Epidemiol. 2018 09; 101:116-118.
-
Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning. Chin Med J (Engl). 2018 Feb 05; 131(3):347-351.